Founders Fund VI Management, LLC

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Founders Fund VI Management, LLC reported 3 stock positions worth $264 thousand. Its top holding was Cyclo Therapeutics (CYTH) at 57.9% of the portfolio, followed by Snap Class A (SNAP, 39.3%) and Nova (NVMI, 2.8%). Compared with Q4 2023, it opened 2 new positions and sold out of 1. The biggest buy was a new position in Snap Class A (SNAP) and the biggest sale an exit from Roivant Sciences (ROIV).